CHS 828,
CHS-828,
GMX 1778,
GMX-1778,
GMX1778,
N-(6-chlorophenoxyhexyl)-N''-cyano-N''-4-pyridylguanidine,
200484-11-3,
CHS-828,
GMX1778,
CHS 828,
CHS828,
UNII-8LAP87DNSZ,
GMX1778(CHS-828),
GMX1778 (CHS828),
8LAP87DNSZ,
CHEMBL17289,
Guanidine, N-[6-(4-chlorophenoxy)hexyl]-N'-cyano-N''-4-pyridinyl-,
2-[6-(4-chlorophenoxy)hexyl]-1-cyano-3-pyridin-4-ylguanidine,
N-Cyano-N'-(6-(p-chlorophenoxy)hexyl)-N"-(4-pyridyl)guanidine,
GMX 1778,
Guanidine, N-(6-(4-chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridinyl-,
AC1L3WMZ,
gmx1778-chs828,
SCHEMBL504150,
SCHEMBL12083293,
SCHEMBL16312347,
BDBM81396,
CHEBI:95016,
KS-00001CPH,
EX-A713,
BOIPLTNGIAPDBY-UHFFFAOYSA-N,
BCP15158,
N-(6-(4-Chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridinylguanidine,
3544AH,
BDBM50435350,
MFCD03700766,
s8117,
ZINC13282570,
AKOS026674121,
AKOS026750302,
AKOS028109359,
AKOS032960393,
CS-3852,
DB12980,
NCGC00345782-01,
AK198948,
HY-10079,
LS-73363,
FT-0700257,
A12515,
J-012977,
BRD-K47335880-001-01-3,
1-[6-(4-Chlorophenoxy)hexyl]-3-cyano-2-pyridin-4-ylguanidine,
1-(6-(4-chlorophenoxy)hexyl)-2-cyano-3-(pyridin-4-yl)guanidine,
N-(6-(4-chlorophenoxy)-hexyl)-N'-cyano-N''-(4-pyridyl)-guanidine,
N-(6-(4-chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridyl guanidine,
D0Y1NC,
C19H22ClN5O,
Cancer therapeutics, LEO Pharma,
GMX-1778,
C19-H22-Cl-N5-O,
CID148198,
C401312,
n-(6-chlorophenoxyhexyl)-n''-cyano-n''-4-pyridylguanidine,